Anticonvulsant properties of the total alkaloid fraction of Rauvolfia ligustrina Roem. et Schult, in male mice

Revista Brasileira de Farmacognosia

Volumn 17, Issue 2, 2007, Pages 176-180

  Quintans Júnior, Lucindo J ^a,b   Silva, Davi A ^b   Siqueira, Jullyana S ^b   De Souza, Maria De Fátima V ^b   Almeida, Reinaldo N ^b   Silva Júnior, René G C ^c  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^c UNIVERSIDADE FEDERAL DO VALE DO SÃO FRANCISCO   (Brazil)

Author keywords

Anticonvulsant activity; Maximal electroshock; Pentylenetetrazol; Picrotoxin; Rauvolfia ligustrina

Indexed keywords

EID: 34347226357     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2007000200007     Document Type: Article

References (29)

1. Agra MF, França PF, Barbosa-Filho JM 2007. Synopsis of the plants known as medicinal and poisonous in Northeast of Brazil. Rev Bras Farmacogn 17: 114-140.
2. Almeida RN, Navarro DS, Assis TA, Medeiros A, Thomas G 1998. Antidepressant effect of an ethanolic extract of the leaves of Cissampelos sympodialis in rats and mice. J Ethnopharmacol 63: 247-252.
3. Almeida RN, Falcâo ACGM, Diniz RST, Quintans-Júnior LJ, Polari RM, Barbosa-Filho JM, Agra MF, Duarte JC, Ferreira CD, Antoniolli AR, Araujo CC 1999. Metodologia para avaliação de plantas com atividade no sistema nervoso central e alguns dados experimentais. Rev Bras Farm 80: 72-76.
4. Almeida RN, Diniz SA, Diniz RST, Quintans-Júnior LJ, Barbosa-Filho JM 2000. Avaliação da toxicidade aguda e da atividade psicofarmacologica dos extratos etanólicos brutos de partes aéreas e raízes de Rauvolfia ligustrina. XVI Simpósio de Plantas Medicinais do Brasil, FM 194, pp 261.
5. Batista CVF, Schipsema J, Verpoorte R, Rech SB, Henriques AT 1996. Indole alkaloids from Rauwolfia sellowii. Phytochemistry 41: 969-973.
6. Barbosa-Filho JM, Martins VKM, Rabelo LA, Moura MD, Silva MS, Cunha EVL, Souza MFV, Almeida RN, Medeiros IA 2006a. Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980-2000. Rev Bras Farmacogn 16: 421-446.
7. Barbosa-Filho JM, Piuvezam MR, Moura MD, Silva MS, Lima KVB, Cunha EVL, Fechine IM, Takemura OS 2006b. Anti-inflammatory activity of alkaloids: A twentycentury review. Rev Bras Farmacogn 16: 109-139.
8. Cancelieri NM, Vieira IJC, Schripsema J, Mathias L, Braz-Filho R 2002. Darcybeirine, a novel pentacyclic indole alkaloid from Rauvolfia grandiflora Mart. Tetrahedron Lett 43: 1783-1787.
9. Dailey JW, Yan QS, Adams-Curtis LE, Ryu JR, Ko KH, Mishra PK, Jobe PC 1996. Neurochemical correlates of antiepoleptic drugs in the genetically epilepsy-prone rats (GEPR). Life Sci 58: 259-266.
10. Dietrich L 1983. A new approach to practical acute toxicity testing. Arch Toxicol 54: 275-287.
11. Faingold CL 1987. Seizures induced by convulsant drug. In P.C. Jobe and H.E. Laird. II (Eds.) Naurotransmitters and Epilepsy. The Humans Press, Clifton, pp 215-275.
12. Kan C, Potier P, Kan S, Jokela R, Lounasmaa M 1986. Indole alkaloids from Rauvolfia media. Phytochemistry 25: 1783-1784.
13. Kasture VS, Kasture SB, Chopde CT 2002. Anticonvulsive activity of Butea monosperma flowers in laboratory animals. Pharmacol Biochem Behav 72: 965-972.
14. Korolkovas A, Burckhalter JH 1976. Anticonvulsants essential of medicinal chemistry. New York: Wiley, p. 105.
15. Lednicer D, Mitscer LA 1977. The organic chemistry of drug synthesis. John Wiley and Sons, New York, 317-320.
16. Lehmann J, Hutchison A, McPherson SE, Mondadori C, Schmutz M, Sinton CM, Tsai C, Murphy DE, Steel DJ, Williams M, Cheney DL, Wood PL 1988. CGS 19755, a selective and competitive N-metil-D-aspartate-type excitatory amino acid receptor antagonist. J Pharmacol Exp Ther 246: 65-75.
17. Löscher W, Schmidt D1988. Which animal model should be used in the search for new antiepileptic drug? A proposal based on experimental and clinical consideration. Epilepsy Res 2: 145-181.
18. Löscher W 1998. New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 342: 1-13.
19. Neuss R 1970. Chemistry of the alkaloids. Van Nortrand Reinhold Company S.W. Pelletier, p. 213-226.
20. N'Gouemo P, Nguemby-Bina C, Baldy-Moulinier M 1994. Some neuropharmacological effects of an ethanolic extract of Maprounea africana in rodents. J Ethnopharmacol 43: 161-166.
21. Ngo Bum E, Schmutz M, Meyer C, Rakotonirina A, Bopelet M, Portet C, Jeker A, Rakotonirina SV, Olpe HR, Herrling P 2001. Anticonvulsant properties of the methanolic extract of Cyperus articulatus (Cyperaceae). J Ethnopharmacol 76: 145-150.
22. Oliveira FA, Almeida RN, Sousa MFV, Barbosa-Filho JM, Diniz SA, Medeiros IA 2001. Anticonvulsant properties of N-salicyloyltryptamine in mice. Pharmacol Biochem Behav 68: 199-202.
23. Quintans-Júnior LJ, Almeida RN, Falcão ACGM, Agra MF, Sousa MFV, Barbosa-Filho JM 2002. Avaliação da Atividade anticonvulsivante de plantas do Nordeste Brasileiro. Acta Farm Bonaerense 21: 179-184.
24. Rao AS 1956. A revision of Rauvolfia with particular reference to the American species. Ann Missour Bot Gard 43: 299-301.
25. Starr MS 1996. The role of dopamine in epilepsy. Synapse 22: 159-194.
26. Swinyard EA, Woodhead JH, White HS, Franklin MR 1989. Experimental selection, qualification and evaluation of anticonvulsant. In: Levy RH, Dreyfuss FE, Mattson RM, Meldrum BS, Penry JK, editors. Antiepileptic drugs. New York: Raven Press, p.85.
27. Tona L, Kambu K, Ngimbi N, Cimanga K, Vlietinck AK 1998. Antiamoebic and phytochemical screening of some Congolese medicinal plants. J Ethnopharmacol 61: 57-65.
28. Tortoriello J, Ortega A 1993. Sedative effect of galphimine B, a Nor-seco-triterpenoid from Galphimia galuca. Planta Med 59: 398-400.
29. st ed., 1-11.